Literature DB >> 3099874

Three years of collaboration on the standardization of Chagas' disease serodiagnosis in the Americas: an appraisal.

M E Camargo, E L Segura, I G Kagan, J M Souza, J da R Carvalheiro, J F Yanovsky, M C Guimarães.   

Abstract

Entities:  

Mesh：

Year:  1986        PMID： 3099874

Source DB:  PubMed          Journal:  Bull Pan Am Health Organ        ISSN： 0085-4638


× No keyword cloud information.
  20 in total

1.  Serologic testing for Trypanosoma cruzi: comparison of radioimmunoprecipitation assay with commercially available indirect immunofluorescence assay, indirect hemagglutination assay, and enzyme-linked immunosorbent assay kits.

Authors:  D A Leiby; S Wendel; D T Takaoka; R M Fachini; L C Oliveira; M A Tibbals
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  Validation of a rapid and reliable test for diagnosis of chagas' disease by detection of Trypanosoma cruzi-specific antibodies in blood of donors and patients in Central America.

Authors:  Carlos Ponce; Elisa Ponce; Elizabeth Vinelli; Alberto Montoya; Vilma de Aguilar; Antonio Gonzalez; Bianca Zingales; Rafael Rangel-Aldao; Mariano J Levin; Javan Esfandiari; Eufrosina S Umezawa; Alejandro O Luquetti; José Franco da Silveira
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

3.  Mass screening for Trypanosoma cruzi infections using the immunofluorescence, ELISA and haemagglutination tests on serum samples and on blood eluates from filter-paper.

Authors:  F Zicker; P G Smith; A O Luquetti; O S Oliveira
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

4.  Evaluation of recombinant antigens for serodiagnosis of Chagas' disease in South and Central America.

Authors:  E S Umezawa; S F Bastos; M E Camargo; L M Yamauchi; M R Santos; A Gonzalez; B Zingales; M J Levin; O Sousa; R Rangel-Aldao; J F da Silveira
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

5.  Use of full-length recombinant calflagin and its c fragment for improvement of diagnosis of Trypanosoma cruzi infection.

Authors:  Iván S Marcipar; Cintia Roodveldt; Gerardo Corradi; María L Cabeza; Maria Edileuza F Brito; Lucile M Floeter Winter; Alberto J Marcipar; Ariel M Silber
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

6.  Design, construction, and evaluation of a specific chimeric antigen to diagnose chagasic infection.

Authors:  Sebastián Aguirre; Ariel M Silber; Maria Edileuza F Brito; María E Ribone; Claudia M Lagier; Iván S Marcipar
Journal:  J Clin Microbiol       Date:  2006-10       Impact factor: 5.948

7.  High resolution of Trypanosoma cruzi amastigote antigen in serodiagnosis of different clinical forms of Chagas' disease.

Authors:  T K Matsumoto; S Hoshino-Shimizu; P M Nakamura; H F Andrade; E S Umezawa
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

8.  Lateral flow immunoassay for diagnosis of Trypanosoma cruzi infection with high correlation to the radioimmunoprecipitation assay.

Authors:  Raymond L Houghton; Yvonne Y Stevens; Kathryn Hjerrild; Jeff Guderian; Masahiko Okamoto; Mazbahul Kabir; Steven G Reed; David A Leiby; W John W Morrow; Myriam Lorca; Syamal Raychaudhuri
Journal:  Clin Vaccine Immunol       Date:  2009-02-11

9.  Trypanosoma cruzi bromodomain factor 3 binds acetylated α-tubulin and concentrates in the flagellum during metacyclogenesis.

Authors:  Victoria Lucia Alonso; Gabriela Vanina Villanova; Carla Ritagliati; María Cristina Machado Motta; Pamela Cribb; Esteban Carlos Serra
Journal:  Eukaryot Cell       Date:  2014-04-18

10.  Trypanosoma cruzi recombinant complement regulatory protein: a novel antigen for use in an enzyme-linked immunosorbent assay for diagnosis of Chagas' disease.

Authors:  Wendell S F Meira; Lúcia M C Galvão; Eliane D Gontijo; George L L Machado-Coelho; Karen A Norris; Egler Chiari
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.